Evidence map›Paper›PMID 31752638›Full record

Trial reportJournal of the American Heart Association2019

Severe Hypouricemia Impairs Endothelium-Dependent Vasodilatation and Reduces Blood Pressure in Healthy Young Men: A Randomized, Placebo-Controlled, and Crossover Study.

Benjamin De Becker, Catherine Coremans, Martin Chaumont, Cédric Delporte, Pierre Van Antwerpen, Thierry Franck, Alexandre Rousseau, Karim Zouaoui Boudjeltia, Pierre Cullus, Philippe van de Borne

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection.Pflugers Archiv : European journal of physiology · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Benjamin De BeckerDepartment of Cardiology Erasme Hospital Université Libre de Bruxelles Brussels Belgium.
Catherine CoremansDepartment A: Research in Drug Development (RD3)-Pharmacognosy, Bioanalysis and Drug Discovery and Analytical Platform of the Faculty of Pharmacy Université Libre de Bruxelles Brussels Belgium.
Martin ChaumontDepartment of Cardiology Erasme Hospital Université Libre de Bruxelles Brussels Belgium.
Cédric DelporteDepartment A: Research in Drug Development (RD3)-Pharmacognosy, Bioanalysis and Drug Discovery and Analytical Platform of the Faculty of Pharmacy Université Libre de Bruxelles Brussels Belgium.
Pierre Van AntwerpenDepartment A: Research in Drug Development (RD3)-Pharmacognosy, Bioanalysis and Drug Discovery and Analytical Platform of the Faculty of Pharmacy Université Libre de Bruxelles Brussels Belgium.
Thierry FranckCentre of Oxygen, Research and Development Institute of Chemistry B 6a University of Liège-Sart Tilman Liège Belgium.
Alexandre RousseauLaboratory of Experimental Medicine (ULB 222) Medicine Faculty Université Libre de Bruxelles Centre Hospitalier Universitaire de Charleroi, Hopital Vesale Montigny-le-Tilleul Belgium.
Karim Zouaoui BoudjeltiaLaboratory of Experimental Medicine (ULB 222) Medicine Faculty Université Libre de Bruxelles Centre Hospitalier Universitaire de Charleroi, Hopital Vesale Montigny-le-Tilleul Belgium.
Pierre CullusBiostatistics Department Medicine Faculty Université Libre de Bruxelles Brussels Belgium.
Philippe van de BorneDepartment of Cardiology Erasme Hospital Université Libre de Bruxelles Brussels Belgium.
Université Libre de Bruxelles · BEHôpital Civil de Charleroi · BEUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Uric acid (UA) is a plasmatic antioxidant that has possible effects on blood pressure. The effects of UA on endothelial function are unclear. We hypothesize that endothelial function is not impaired unless significant UA depletion is achieved through selective xanthine oxidase inhibition with febuxostat and recombinant uricase (rasburicase). Methods and Results Microvascular hyperemia, induced by iontophoresis of acetylcholine and sodium nitroprusside, and heating-induced local hyperemia after iontophoresis of saline and a specific nitric oxide synthase inhibitor were assessed by laser Doppler imaging. Blood pressure and renin-angiotensin system markers were measured, and arterial stiffness was assessed. CRP (C-reactive protein), allantoin, chlorotyrosine/tyrosine ratio, homocitrulline/lysine ratio, myeloperoxidase activity, malondialdehyde, and interleukin-8 were used to characterize inflammation and oxidative stress. Seventeen young healthy men were enrolled in a randomized, double-blind, placebo-controlled, 3-way crossover study. The 3 compared conditions were placebo, febuxostat alone, and febuxostat together with rasburicase. The allantoin (μmol/L)/UA (μmol/L) ratio differed between sessions (

Indexed as

AdultBlood PressureCross-Over StudiesDouble-Blind MethodEndothelium, VascularFebuxostatHumansMaleMicrovesselsSeverity of Illness IndexUrate OxidaseUric AcidVasodilationXanthine OxidaseYoung AdultFebuxostatrasburicaseUrate OxidaseUric AcidXanthine Oxidasefebuxostatnitric oxide synthaserasburicaserenin‐angiotensin‐aldosterone system

Identifiers

PMID31752638
PMCPMC6912967
OpenAlexW2991138826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.